{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:49:50Z","timestamp":1776199790502,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver (NAFLD) is a chronic disease worldwide, which poses a huge threat to human health. Xiaochaihu decoction is a well-known traditional Chinese medicine prescription. It has been proven effective in treating NAFLD but its mechanism is still unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Multiple mechanisms of Xiaochaihu decoction are explored by identifying and connecting potential targets and active ingredients in the treatment of NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Active ingredients and related targets of seven herbs were collected from TCMSP database. The related targets of NAFLD were obtained from Genes cards database, TDD and OMIM database. The intersected targets of disease targets and drug targets were input into STRING database to construct protein-protein interaction network. DAVID database was used for GO enrichment analysis and KEGG enrichment analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After screening and removal of duplicates, a total of 145 active ingredients and 105 potential targets were obtained. PPI network manifested that AKT1, IL6, JUN MAPK8 and STAT3 were the key target proteins. The results of GO enrichment analysis mainly involved cytokine receptor binding, cytokine activity, and heme binding. The results of KEGG analysis suggested that the mechanism mainly involved in AGE-RAGE signaling pathway in diabetic complications, Hepatitis C, fluid shear stress and atherosclerosis. The signaling pathways were further integrated as network manner, including AGE-RAGE signaling pathway in diabetic complications, Fluid shear stress and atherosclerosis, Insulin resistance, HIF-1 signaling pathway, Th17 cell differentiation and IL-17 signaling pathway. The network contained immunity regulation, metabolism regulation and oxidative stress regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Xiaochaihu decoction plays a key role in the treatment of NAFLD with multiple targets and pathways. Immunity regulation, metabolism regulation and oxidative stress regulation consist of the crucial regulation cores in mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                    <jats:p>Design and workflow of this study<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13040-020-00224-9","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T10:02:47Z","timestamp":1598522567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1646-3347","authenticated-orcid":false,"given":"Qichao","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizhang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinxiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"224_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00204-016-1892-7","volume":"91","author":"SM Alwahsh","year":"2017","unstructured":"Alwahsh SM, Gebhardt R, et al. Arch Toxicol. 2017;91:1545\u201363 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27995280.","journal-title":"Arch Toxicol"},{"key":"224_CR2","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/hep.30489","volume":"69","author":"F Kanwal","year":"2019","unstructured":"Kanwal F, Tapper EB, Ho C, Asrani SK, Ovchinsky N, Poterucha J, et al. Development of quality measures in cirrhosis by the practice metrics Committee of the American Association for the study of liver diseases. Hepatology. 2019;69:1787\u201397.","journal-title":"Hepatology."},{"key":"224_CR3","doi-asserted-by":"publisher","unstructured":"Fan JG, Kim SU, Wong VWS. New trends on obesity and NAFLD in Asia. J Hepatol. 2017. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.003 European Association for the Study of the liver.","DOI":"10.1016\/j.jhep.2017.06.003"},{"key":"224_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","volume":"17","author":"S Sutti","year":"2020","unstructured":"Sutti S, Albano E. Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol. 2020;17:81\u201392. https:\/\/doi.org\/10.1038\/s41575-019-0210-2 Springer US.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"224_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2018.01256","volume":"9","author":"A Turchinovich","year":"2018","unstructured":"Turchinovich A, Baranova A, Drapkina O, Tonevitsky A. Cell-free circulating nucleic acids as early biomarkers for NAFLD and NAFLD-associated disorders. Front Physiol. 2018;9:1\u201313.","journal-title":"Front Physiol"},{"key":"224_CR6","first-page":"1327","volume":"46","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Jiang Y, Zheng P. 1. Research Progress in traditional Chinese medicine of nonalcoholic fatty liver. J Liaoning Univ Tradit Chin Med. 2019;46:1327\u201330.","journal-title":"J Liaoning Univ Tradit Chin Med"},{"key":"224_CR7","doi-asserted-by":"crossref","first-page":"8749564","DOI":"10.1155\/2020\/8749564","volume":"2020","author":"T Shi","year":"2020","unstructured":"Shi T, Wu L, Ma W, Ju L, Bai M, Chen X, et al. Nonalcoholic fatty liver disease: pathogenesis and treatment in traditional Chinese medicine and Western medicine. Evid Based Complement Alternat Med. 2020;2020:8749564.","journal-title":"Evid Based Complement Alternat Med"},{"key":"224_CR8","first-page":"122","volume":"21","author":"Z Ruoxuan","year":"2019","unstructured":"Ruoxuan Z, Wenliang L. Research Progress in treatment of nonalcoholic fatty liver disease by Chinese medicine. J Hubei Univ Chinese Med. 2019;21:122\u20135.","journal-title":"J Hubei Univ Chinese Med"},{"key":"224_CR9","first-page":"400","volume":"34","author":"G Qiu","year":"2013","unstructured":"Qiu G, Ye F, Liu Y, Cai Y, Wang R, Sun Y, He Q. The experimental study on the effects of Xiaochaihu Soup on nonalcoholic rat fatty liver. J Xi\u2019an Jiaotong Univ Medical Sci. 2013;34:400\u20132.","journal-title":"J Xi\u2019an Jiaotong Univ Medical Sci"},{"key":"224_CR10","first-page":"7826769","volume":"2019","author":"JF Liu","year":"2019","unstructured":"Liu JF, Hu AN, Zan JF, Wang P, You QY, Tan AH, et al. Network pharmacology deciphering mechanisms of volatiles of Wendan granule for the treatment of Alzheimer\u2019s disease. Evid Based Complement Alternat Med. 2019;2019:7826769.","journal-title":"Evid Based Complement Alternat Med"},{"key":"224_CR11","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2147\/DDDT.S207955","volume":"13","author":"B Niu","year":"2019","unstructured":"Niu B, Zhang H, Li C, Yan F, Song Y, Hai G, et al. Network pharmacology study on the active components of pterocypsela elata and the mechanism of their effect against cerebral ischemia. Drug Des Devel Ther. 2019;13:3009\u201319.","journal-title":"Drug Des Devel Ther"},{"key":"224_CR12","first-page":"1","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. Aust J Chem. 2014;6:1\u20136.","journal-title":"Aust J Chem"},{"key":"224_CR13","first-page":"11","volume":"7","author":"SSSJ Ahmed","year":"2012","unstructured":"Ahmed SSSJ, Ramakrishnan V. Systems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability prediction. PLoS One. 2012;7:11\u20137.","journal-title":"PLoS One"},{"key":"224_CR14","first-page":"D1031","volume":"48","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang S, Li F, Zhou Y, Zhang Y, Wang Z, et al. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res. 2020;48:D1031\u201341 Oxford University Press.","journal-title":"Nucleic Acids Res"},{"key":"224_CR15","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"A Bateman","year":"2019","unstructured":"Bateman A. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47:D506\u201315 Oxford University Press.","journal-title":"Nucleic Acids Res"},{"key":"224_CR16","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362\u20138.","journal-title":"Nucleic Acids Res"},{"key":"224_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-426","volume":"8","author":"BT Sherman","year":"2007","unstructured":"Sherman BT, Huang DW, Tan Q, Guo Y, Bour S, Liu D, et al. DAVID knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics. 2007;8:1\u201311.","journal-title":"BMC Bioinformatics"},{"key":"224_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology."},{"key":"224_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","volume":"59","author":"F Nascimbeni","year":"2013","unstructured":"Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, et al. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59:859\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2013.05.044 European Association for the Study of the Liver.","journal-title":"J Hepatol"},{"key":"224_CR20","doi-asserted-by":"publisher","unstructured":"Ballestri S, Capitelli M, Fontana MC, Arioli D, Romagnoli E, Graziosi C, et al. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. Adv Ther; 2020: 1910-1932: https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s12325-020-01307-z. Springer Healthcare.","DOI":"10.1007\/s12325-020-01307-z"},{"key":"224_CR21","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1248\/bpb.b18-00132","volume":"41","author":"Y Xu","year":"2018","unstructured":"Xu Y, Yang C, Zhang S, Li J, Xiao Q, Huang W. Ginsenoside Rg1 protects against non-alcoholic fatty liver disease by ameliorating lipid peroxidation, endoplasmic reticulum stress, and Inflammasome activation. Biol Pharm Bull. 2018;41:1638\u201344.","journal-title":"Biol Pharm Bull"},{"key":"224_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.lfs.2017.11.027","volume":"192","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang H, Deng X, Zhang N, Liu B, Xin S, et al. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. Life Sci. 2018;192:46\u201354. https:\/\/doi.org\/10.1016\/j.lfs.2017.11.027 Elsevier.","journal-title":"Life Sci"},{"key":"224_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.00001","volume":"11","author":"X Ma","year":"2020","unstructured":"Ma X, Zhang W, Jiang Y, Wen J, Wei S, Zhao Y. Paeoniflorin, a natural product with multiple targets in liver diseases\u2014a mini review. Front Pharmacol. 2020;11:1\u20137.","journal-title":"Front Pharmacol"},{"key":"224_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.fct.2018.02.019","volume":"114","author":"X Zhu","year":"2018","unstructured":"Zhu X, Xiong T, Liu P, Guo X, Xiao L, Zhou F, et al. Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a\/XBP1s pathway. Food Chem Toxicol. 2018;114:52\u201360. https:\/\/doi.org\/10.1016\/j.fct.2018.02.019 Elsevier.","journal-title":"Food Chem Toxicol"},{"key":"224_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7762\/cnr.2020.9.1.11","volume":"9","author":"Y Pasdar","year":"2020","unstructured":"Pasdar Y, Oubari F, Zarif MN, Abbasi M, Pourmahmoudi A, Hosseinikia M. Effects of Quercetin supplementation on hematological parameters in non-alcoholic fatty liver disease: a randomized, double-blind, Placebo-Controlled Pilot Study. Clin Nutr Res. 2020;9:11.","journal-title":"Clin Nutr Res"},{"key":"224_CR26","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1111\/jcmm.14528","volume":"23","author":"T Xu","year":"2019","unstructured":"Xu T, Huang S, Huang Q, Ming Z, Wang M, Li R, et al. Kaempferol attenuates liver fibrosis by inhibiting activin receptor\u2013like kinase 5. J Cell Mol Med. 2019;23:6403\u201310.","journal-title":"J Cell Mol Med"},{"key":"224_CR27","doi-asserted-by":"publisher","first-page":"152338","DOI":"10.1016\/j.tox.2019.152338","volume":"429","author":"J Chen","year":"2020","unstructured":"Chen J, Xuan YH, Luo MX, Ni XG, Ling LQ, Hu SJ, et al. Kaempferol alleviates acute alcoholic liver injury in mice by regulating intestinal tight junction proteins and butyrate receptors and transporters. Toxicology. 2020;429:152338. https:\/\/doi.org\/10.1016\/j.tox.2019.152338 Elsevier Ireland Ltd.","journal-title":"Toxicology"},{"issue":"10","key":"224_CR28","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.bbalip.2018.08.004","volume":"1863","author":"S Feng","year":"2018","unstructured":"Feng S, Dai Z, Liu AB, Huang J, Narsipur N, Guo G, et al. Intake of stigmasterol and \u03b2-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(10):1274\u201384. https:\/\/doi.org\/10.1016\/j.bbalip.2018.08.004 Elsevier B.V.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"224_CR29","first-page":"4685","volume":"43","author":"Y He","year":"2018","unstructured":"He Y, Liu C, He C, Zhao J, Sun Y, Xu H, et al. Protective effect of Fuzheng Yanggan mixture on drug-induced liver injury. China J Chinese Mater Medica. 2018;43:4685\u201391.","journal-title":"China J Chinese Mater Medica"},{"key":"224_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.mce.2011.09.001","volume":"348","author":"Z Yang","year":"2012","unstructured":"Yang Z, Wen J, Li Q, Tao X, Ye Z, He M, et al. PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population. Mol Cell Endocrinol. 2012;348:255\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"224_CR31","first-page":"6254340","volume":"2018","author":"X Xie","year":"2018","unstructured":"Xie X, Yan D, Li H, Zhu Q, Li J, Fang YP, et al. Enhancement of Adiponectin ameliorates nonalcoholic fatty liver disease via inhibition of FoxO1 in type 1 diabetic rats. J Diabetes Res. 2018;2018:6254340.","journal-title":"J Diabetes Res"},{"key":"224_CR32","first-page":"1","volume":"53","author":"H Wu","year":"2020","unstructured":"Wu H, Chen G, Wang J, Deng M, Yuan F, Gong J. TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1\/Mitophagy signalling pathway. Cell Prolif. 2020;53:1\u201315.","journal-title":"Cell Prolif"},{"key":"224_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/apm.12696","volume":"125","author":"OM Hendy","year":"2017","unstructured":"Hendy OM, Elsabaawy MM, Aref MM, Khalaf FM, Oda AMA, El Shazly HM. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease. Apmis. 2017;125:607\u201313.","journal-title":"Apmis."},{"key":"224_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1042\/BCJ20190799","volume":"477","author":"FJ Yan","year":"2020","unstructured":"Yan FJ, Wang X, Wang SE, Hong HT, Lu J, Ye Q, et al. C-Jun\/C7ORF41\/NF-\u03baB axis mediates hepatic inflammation and lipid accumulation in NAFLD. Biochem J. 2020;477:691\u2013708.","journal-title":"Biochem J"},{"key":"224_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jhep.2018.04.017","volume":"69","author":"M Langiewicz","year":"2018","unstructured":"Langiewicz M, Graf R, Humar B, Clavien PA. JNK1 induces hedgehog signaling from stellate cells to accelerate liver regeneration in mice. J Hepatol. 2018;69:666\u201375. https:\/\/doi.org\/10.1016\/j.jhep.2018.04.017 European Association for the Study of the Liver.","journal-title":"J Hepatol"},{"key":"224_CR36","doi-asserted-by":"publisher","first-page":"4021623","DOI":"10.1155\/2019\/4021623","volume":"2019","author":"YJ Heo","year":"2019","unstructured":"Heo YJ, Choi SE, Jeon JY, Han SJ, Kim DJ, Kang Y, et al. Visfatin induces inflammation and insulin resistance via the NF-\u03baB and STAT3 signaling pathways in hepatocytes. J Diabetes Res. 2019;2019:4021623.","journal-title":"J Diabetes Res"},{"issue":"6","key":"224_CR37","doi-asserted-by":"publisher","first-page":"BSR20181304","DOI":"10.1042\/BSR20181304","volume":"38","author":"F Tian","year":"2018","unstructured":"Tian F, Zheng Z, Zhang D, He S, Shen J. Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease. Biosci Rep. 2018;38(6):BSR20181304.","journal-title":"Biosci Rep"},{"key":"224_CR38","doi-asserted-by":"publisher","first-page":"2151302","DOI":"10.1155\/2019\/2151302","volume":"2019","author":"K Asadipooya","year":"2019","unstructured":"Asadipooya K, Lankarani KB, Raj R, Kalantarhormozi M. RAGE is a potential cause of onset and progression of nonalcoholic fatty liver disease. Int J Endocrinol. 2019;2019:2151302.","journal-title":"Int J Endocrinol"},{"key":"224_CR39","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.tem.2019.08.008","volume":"30","author":"D Stols-Gon\u00e7alves","year":"2019","unstructured":"Stols-Gon\u00e7alves D, Hovingh GK, Nieuwdorp M, Holleboom AG. NAFLD and atherosclerosis: two sides of the same Dysmetabolic coin? Trends Endocrinol Metab. 2019;30:891\u2013902.","journal-title":"Trends Endocrinol Metab"},{"key":"224_CR40","first-page":"64","volume":"47","author":"R Wang","year":"2019","unstructured":"Wang R, Li D, Qi W, Sun J, et al. 1. Expression and clinical significance of HIF-1\u03b1 and Th17 \/ Treg in peripheral blood of patients with non-alcoholic fatty liver disease. Clin J Med Off. 2019;47:64\u20135.","journal-title":"Clin J Med Off"},{"key":"224_CR41","doi-asserted-by":"publisher","first-page":"205873921880267","DOI":"10.1177\/2058739218802678","volume":"16","author":"S-B Su","year":"2018","unstructured":"Su S-B, Chen W, Huang F-F, Zhang J-F. Elevated Th22 cells correlated with Th17 cells in patients with high liver stiffness in nonalcoholic fatty liver disease. Eur J Inflamm. 2018;16:205873921880267.","journal-title":"Eur J Inflamm"},{"key":"224_CR42","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/ptr.6621","volume":"34","author":"X Ma","year":"2020","unstructured":"Ma X, Jiang Y, Zhang W, Wang J, Wang R, Wang L, et al. Natural products for the prevention and treatment of cholestasis: a review. Phyther Res. 2020;34:1291\u2013309.","journal-title":"Phyther Res"}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-020-00224-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-020-00224-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-020-00224-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T13:53:07Z","timestamp":1723470787000},"score":1,"resource":{"primary":{"URL":"https:\/\/biodatamining.biomedcentral.com\/articles\/10.1186\/s13040-020-00224-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1186\/s13040-020-00224-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-29961\/v1","asserted-by":"object"}]},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}